Lilly Invests In Chinese Generics | Chemical & Engineering News
Volume 90 Issue 25 | p. 21 | Concentrates
Issue Date: June 18, 2012

Lilly Invests In Chinese Generics

Department: Business
Keywords: pharmaceuticals, generics, manufacturing, China

Eli Lilly & Co. is expanding its manufacturing network through a new investment in Novast Laboratories, a Chinese maker of generics and specialty drugs. Lilly invested in Novast several years ago through its Lilly Asian Ventures unit and will now invest an additional $20 million in the firm.With Lilly’s help to enhance quality standards, Novast will expand production capacity so it can manufacture branded generic medicines from Lilly. Ultimately, Novast may make proprietary Lilly drugs.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment